Health CarePharmaceuticals & Biotechnology
  • Price (USD)157.50
  • Today's Change0.530 / 0.34%
  • Shares traded653.58k
  • 1 Year change32.80%
  • Beta1.4324
Data delayed at least 15 minutes, as of May 25 2018 21:00 BST.
More ▼

Key statistics

On Friday, Vertex Pharmaceuticals Inc (VRTX:NSQ) closed at 157.50, -11.64% below its 52-week high of 178.25, set on Mar 13, 2018.
52-week range
117.38May 25 2017178.25Mar 13 2018
Markit short selling activity
Previous close156.97
Average volume1.15m
Shares outstanding254.83m
Free float253.59m
P/E (TTM)184.22
Market cap40.14bn USD
EPS (TTM)0.8549
Data delayed at least 15 minutes, as of May 25 2018 21:00 BST.
More ▼
© Thomson Reuters Click for restrictions
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.